Recent news on Valrubicin

Indevus Announces Submission of Supplemental NDA to Reintroduce ...  -  Apr 19, 2007
PipelineReview.com (press release),VALSTAR is a sterile solution for intravesical (bladder) instillation of valrubicin, a chemotherapeutic anthracycline derivative.

Risa Bernstein, Agency Co-Founder, Returns to Flashpoint Medica  -  Jan 17, 2007
PharmaLive.com (press release),...a hormone replacement patch, Valera for Valstar (Valrubicin) a bladder cancer agent, Vantas for prostate cancer and Supprelin for precocious puberty.

Valera Pharmaceuticals Reports Third Quarter 2006 Financial ...  Nov 8, 2006
...small batch production studies, Valera observed an unacceptable degradation of an excipient, or additive, used with the active drug valrubicin in formulating ... -Market Wire (press release)

Valera Pharmaceuticals Acquires Rights to VALSTAR; Only FDA ...  Apr 3, 2006
...that the Company completed its acquisition of the New Drug Application and other assets associated with the product known as VALSTAR(R) (valrubicin) in the US ... - International News Service

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional